Short‐acting β(2)‐agonist use and asthma exacerbations in Swedish children: A SABINA Junior study
BACKGROUND: In adults and adolescents with asthma, use of ≥3 short‐acting β(2)‐agonist (SABA) canisters/year is associated with increased exacerbation risk. Whether this association is present in younger children remains unknown. In this SABA use IN Asthma (SABINA) Junior study, we assessed the asso...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828275/ https://www.ncbi.nlm.nih.gov/pubmed/36433853 http://dx.doi.org/10.1111/pai.13885 |